Navigation Links
TouchMark Announces New Sales Representative
Date:5/20/2009

HAYWARD, Calif., May 20 /PRNewswire/ -- TouchMark a division of Delphon Industries and industry leader in Electronic and Medical Device Pad Printing, announced today the appointment of Diablo Sales & Marketing to provide technical applications and sales support in the western United States and Western Canada.

Diablo Sales and Marketing is one of the leading manufacturers' representative organizations specializing in high quality components and materials used in injection molding and extrusion for the medical device and high technology sectors. Diablo has engineering sales offices located in the Bay Area, Southern California, Colorado and the Pacific Northwest and are strategically located to service their medical device customers. TouchMark will work with Diablo's engineering and sales resources in order to deliver more complete manufacturing solutions to its customers.

"We're confident that our new relationship with Diablo Sales and Marketing will provide our West Coast customers with a higher level of local technical sales support," says Raymund Abiera, Sales Manager for TouchMark.

Background:

TouchMark, originally founded in 1992, was purchased by Delphon Industries in 2006. For more than 15 years the company has worked closely with leading electronics and medical customers to provide solutions to their pad printing challenges. TouchMark has developed an expertise with difficult substrates, inks and unique shapes. In addition to pad printing, the ISO Certified company has expanded its offerings over the years to include material procurement and preparation, incoming inspection, Cleanroom assembly, as well as post production services. The company is constantly growing its service menu to meet the changing needs of medical device and consumer electronic manufactures.

    For More Information:
    Contact:       Darby Davis: 510-576-2220 '/>"/>
SOURCE TouchMark
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. TouchMark Offers Complimentary NRE
2. Sagent Pharmaceuticals Announces Extension of Series A Financing
3. Covidien announces milestone placement in remote respiratory monitoring
4. National Small Business Week Update: Sam's Club Announces Simplified Small Business Membership; Partnership With U.S. Chamber of Commerce, Plus Free One-Day Pass
5. US Farms, Inc. Announces Membership to Natural Products Association
6. Aragon Pharmaceuticals Announces $8 Million Series A Financing
7. Asymchem Announces Opening of High Potency API and Drug Product Facility
8. TrinityCare Senior Living, Inc. Announces First Quarter Operating Results
9. SXC Health Solutions announces agreements for pharmacy technology services with Prime Therapeutics LLC
10. Recondo Technology Announces Two New Board Members
11. Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Promising device snags young inventors coveted spot at IShow 8813 1Promising device snags young inventors coveted spot at IShow 8813 2Promising device snags young inventors coveted spot at IShow 8813 3Cogdell Spencer Inc Declares Quarterly Dividend 48744 1Cogdell Spencer Inc Declares Quarterly Dividend 48744 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 1New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 2New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 3New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 4New Test from Quest Diagnostics Helps Physicians Choose HIV Antiretroviral Therapy in Patients with History of Drug Resistance 12598 5